Hummingbird Bioscience Holdings Limited

formerly Hummingbird Bioscience

Home | Hummingbird Bioscience

Singapore, Singapore · Founded 2015 · $169.0M raised

Headquarters
Singapore
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$169.0M
Last Round
$125.0M Series CJan 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Hummingbird Bioscience is a Singapore-based precision biotherapeutics company founded in 2015 that develops a broad pipeline of novel antibody and antibody-drug conjugate (ADC) therapeutics for cancer and other hard-to-treat diseases. The company applies systems biology and computational approaches to uncover novel disease biology, aiming to deliver deep and durable responses for patients. Its clinical-stage programs include HMBD-001 and HMBD-501, and its board includes representatives from investment firms such as Frazier Life Sciences, Novo Holdings, and Decheng Capital.

Summary

Hummingbird Bioscience Holdings Limited is a Biotech company based in Singapore, Singapore, founded in 2015. It has raised $169.0M in total across 3 rounds, most recently a $125.0M Series C round in Jan 2020. Investors include Polaris Partners, Novo Holdings A/S and Frazier Healthcare.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries C2020 (est.)
$125.0M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hummingbird Bioscience Holdings Limited on Indexed.vc
<a href="https://indexed.vc/companies/hummingbird-bioscience-holdings-limited"><img src="https://indexed.vc/api/badge/company/hummingbird-bioscience-holdings-limited" alt="Hummingbird Bioscience Holdings Limited on Indexed.vc" width="260" height="76" /></a>